Table 1.
Gene | Nucleotide change | Amino acid change | Mutation type | Zygosity | Impact on V-ATPase | Associated disease | Variant identifier | Reference |
---|---|---|---|---|---|---|---|---|
ATP6V0A1 | c.T1429C | p.S477P | Missense | Heterozygous | Alters conformation of luminal channel, hindering proton translocation | DEE | VAR_087489 | Bott et al. (2021) |
ATP6V0A1 | c.C1483T | p.R495W | Missense | Compound heterozygous with frameshift mutation: c.445delG, p.E149Kfs18 | Loss of positively charged residue near the luminal channel exit hinders proton translocation | PME and ataxia | rs781278654 | Bott et al. (2021) |
ATP6V0A1 | c.C1513G | p.A505P | Missense | Compound heterozygous with deletion: c.del(17)(q21.2) | Undetermined | DEE | VAR_087491 | Aoto et al. (2021) |
ATP6V0A1 | c.A1579G | p.N527D | Missense | Compound heterozygous with splice site mutation: c.196+1G>A | Undetermined | DEE | rs766856192 | Aoto et al. (2021) |
ATP6V0A1 | c.G1652A | p.G551E | Missense | Heterozygous | Deforms environment mediating proton exchange | DEE | VAR_087493 | Bott et al. (2021) |
ATP6V0A1 | c.G2219A | p.R740Q | Missense | Heterozygous | Impedes glutamate protonation thereby disrupting proton translocation | DEE, PME, autism, microcephaly | rs1567871600 | Aoto et al. (2021); Bott et al. (2021) |
ATP6V0A1 | c.G2411A | p.R804H | Missense | Heterozygous | Impedes glutamate protonation thereby disrupting proton translocation | DEE | VAR_087495 | Bott et al. (2021) |
ATP6V0A2 | c.187T | p.R63X | Nonsense | Homozygous | Truncated protein, non-functional subunit a2 | ARCL II | rs80356750 | Kornak et al. (2008) |
ATP6V0A2 | c.C1214T | p.P405L | Missense | Homozygous | Compromises subunit a2 stability, complex assembly and Golgi trafficking | ARCL II | rs750788949 | Hucthagowder et al. (2009); Esmail et al. (2018a) |
ATP6V0A2 | c.C2293T | p.Q765X | Nonsense | Homozygous | Truncated protein, non-functional subunit a2 | ARCL II | rs80356758 | Kornak et al. (2008) |
ATP6V0A2 | c.C2432C | p.L811P | Missense | Compound heterozygous with splicing mutation: c.2055+2dupT | Changes last α-helix conformation, hindering subunit interactions and proton translocation | ARCL II | rs778642108 | Fischer et al. (2012) |
ATP6V0A3 | c.IVS2+4A→T | p.V26-D39del | Deletion | Homozygous | Unable to assemble with V1 subunit | MIOP | N/A | Kornak et al. (2000) |
ATP6V0A3 | c.G1024T | p.E342X | Stop | Heterozygous | Truncated protein, non-functional subunit a3 | MIOP | N/A | Sobacchi et al. (2001); Susani et al. (2004) |
ATP6V0A3 | c.G1213A | p.G405R | Missense | Homozygous or compound heterozygous with R444L | Steric hindrance of 1st cytoplasmic loop | MIOP | VAR_019569 | Sobacchi et al. (2001); Susani et al. (2004) |
ATP6V0A3 | c.G1331T | p.R444L | Missense | Homozygous or compound heterozygous with G405R | Protein instability due to hydrophobic Arginine (R) | MIOP | rs137853151 | Sobacchi et al. (2001); Susani et al. (2004) |
ATP6V0A3 | c.G2412A | p.W805X (updated NM_006019.4) | Stop | Heterozygous | Truncated protein, non-functional subunit a3 | MIOP | rs1555000308 | Kornak et al. (2000) |
1. ATP6V0A4 2. ATP6V1B1 | 1.c.C419T 2.c.A437G | 1. p.T140M 2. p.D146G | Missense | Digenic heterozygous | 1. Slight conformational change hindering subunit trafficking and assembly 2. Alteration of subunit surface charge leading to the disruption of ATP binding sites | dRTA | 1. rs144802156 2. rs782681801 | Nagara et al. (2018) |
ATP6V0A4 | c.C1631T | p.S544L | Missense | Heterozygous | Unable to bind to B1 subunit, assembly issues, weakened ATPase activity | Complete and incomplete dRTA | rs1026435 | Imai et al. (2016); Chen et al. (2020) |
ATP6V0A4 | c.G2420A | p.R807Q | Missense | Homozygous | Reduction of subunit a4 production leading to V-ATPase assembly and activity deficits | dRTA, Sensorineural hearing loss | rs28939081 | Stover et al. (2002) |
ATP6V0A4 | c.G2458C | p.G820R | Missense | Homozygous | Loss of a4 binding to phosphofructokinase-1, formation of salt bridge disrupting proton translocation | dRTA | rs267606671 | Esmail et al. (2018a) |
ARCL II, autosomal recessive cutis laxa type II; DEE, developmental and epileptic encephalopathies; dRTA, distal renal tubular acidosis; MIOP, malignant infantile osteopetrosis; PME, progressive myoclonus epilepsy.